| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $14.9M | — | +13.2% |
| Cost of Revenue | $7.0M | — | +10.1% |
| Gross Profit | $7.8M | — | +16.1% |
| R&D Expense | $3.6M | — | +7.4% |
| SG&A Expense | $5.1M | — | +31.9% |
| Operating Income | -$2.7M | — | -40.6% |
| Pre-tax Income | -$293K | — | +74.2% |
| Income Tax | $3K | — | -90.0% |
| Net Income | -$296K | — | +74.6% |
| EPS (Basic) | -$0.01 | — | +80.0% |
| EPS (Diluted) | -$0.01 | — | +80.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $40.5M | -8.9% | -3.9% |
| Accounts Receivable | $10.2M | +25.5% | -19.1% |
| Inventory | $11.3M | +4.9% | +2.4% |
| Current Assets | $63.7M | -2.2% | -4.5% |
| Total Assets | $83.2M | -1.7% | +3.7% |
| Current Liabilities | $11.1M | -17.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $570K | — | -60.4% |
| Capital Expenditures | $4.4M | — | +377.0% |
| Investing Cash Flow | -$4.8M | — | -247.5% |
| Financing Cash Flow | $308K | — | +2466.7% |
| Free Cash Flow | -$3.8M | — | -818.2% |
| -12.0% |
| Long-term Debt | $16K | +6.7% | -98.8% |
| Total Liabilities | $12.9M | -17.5% | -24.7% |
| Stockholders' Equity | $70.2M | +1.9% | +11.4% |